O. Donnay

771 total citations
22 papers, 477 citations indexed

About

O. Donnay is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, O. Donnay has authored 22 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 5 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in O. Donnay's work include Cancer Immunotherapy and Biomarkers (10 papers), Colorectal Cancer Treatments and Studies (6 papers) and Multiple and Secondary Primary Cancers (4 papers). O. Donnay is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Colorectal Cancer Treatments and Studies (6 papers) and Multiple and Secondary Primary Cancers (4 papers). O. Donnay collaborates with scholars based in Spain and Canada. O. Donnay's co-authors include Vilma Pacheco-Barcía, Jacobo Rogado, Rámón Colomer, Javier Aspa, J.M. Sánchez-Torres, Nuria Romero-Laorden, Ana M. Ramos‐Leví, Pedro Gullón, Arántzazu Alfranca and Magdalena Adrados and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

O. Donnay

22 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
O. Donnay Spain	8	368	112	85	67	55	22	477
Tarık Salman Türkiye	16	314 0.9×	107 1.0×	109 1.3×	83 1.2×	34 0.6×	67	585
Oliver Higuera Spain	13	305 0.8×	135 1.2×	66 0.8×	40 0.6×	20 0.4×	40	480
Kunal C. Kadakia United States	13	208 0.6×	90 0.8×	93 1.1×	82 1.2×	15 0.3×	43	455
Nilüfer Avcı Türkiye	13	227 0.6×	107 1.0×	46 0.5×	43 0.6×	26 0.5×	39	438
Alice Avancini Italy	15	448 1.2×	173 1.5×	59 0.7×	156 2.3×	18 0.3×	75	651
Katerina Zakka United States	12	191 0.5×	58 0.5×	87 1.0×	62 0.9×	17 0.3×	36	372
Alessandro Iaculli Italy	10	252 0.7×	76 0.7×	45 0.5×	118 1.8×	45 0.8×	17	517
Lorenzo Dottorini Italy	13	330 0.9×	143 1.3×	61 0.7×	167 2.5×	48 0.9×	42	664
Anneli Elme Estonia	11	374 1.0×	230 2.1×	128 1.5×	41 0.6×	26 0.5×	23	524
Capucine Baldini France	10	184 0.5×	96 0.9×	46 0.5×	41 0.6×	12 0.2×	19	336

Countries citing papers authored by O. Donnay

Since Specialization

Citations

This map shows the geographic impact of O. Donnay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Donnay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Donnay more than expected).

Fields of papers citing papers by O. Donnay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Donnay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Donnay. The network helps show where O. Donnay may publish in the future.

Co-authorship network of co-authors of O. Donnay

This figure shows the co-authorship network connecting the top 25 collaborators of O. Donnay. A scholar is included among the top collaborators of O. Donnay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Donnay. O. Donnay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mondéjar, Rebeca, et al.. (2024). Is Older Age an Independent Prognostic Factor of Survival in Metastatic Colorectal Cancer?. Oncology. 102(9). 747–758. 1 indexed citations

Montés, Ana Fernández, Javier Ros, Pilar García‐Alfonso, et al.. (2023). Effectiveness and safety of encorafenib-cetuximab in BRAF^V600E metastatic colorectal cancer: Confidence study.. Journal of Clinical Oncology. 41(4_suppl). 126–126. 2 indexed citations

Rogado, Jacobo, Fernando Campo del Pozo, Kevin Troulé, et al.. (2022). Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC. Cancers. 14(12). 2898–2898. 8 indexed citations

Rogado, Jacobo, Fernando Campo del Pozo, Kevin Troulé, et al.. (2022). Excess weight and anti-PD-1 immune checkpoint inhibitor’s outcomes in non-small cell lung cancer. Clinical & Translational Oncology. 24(11). 2241–2249. 1 indexed citations

France, T., Jamil Asselah, R. Mondéjar, et al.. (2020). 153P The Systemic Inflammation Response Index (SIRI) is a prognostic factor that correlates with tumor burden in advanced pancreatic cancer. Annals of Oncology. 31. S300–S300. 1 indexed citations

Calderón, Caterina, Alberto Carmona‐Bayonas, Raquel Hernández, et al.. (2019). Incidence of sleep problems and their mediating role on depression and anxious preoccupation in patients with resected, non-advanced cancer: data from NEOcoping study. Clinical & Translational Oncology. 21(8). 1104–1107. 5 indexed citations

Peñas, R. de las, Margarita Majem, Juan Antonio Virizuela, et al.. (2019). SEOM clinical guidelines on nutrition in cancer patients (2018). Clinical & Translational Oncology. 21(1). 87–93. 70 indexed citations

Pacheco-Barcía, Vilma, T. France, Jamil Asselah, et al.. (2019). A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer. Pancreatology. 20(2). 254–264. 57 indexed citations

Rogado, Jacobo, J.M. Sánchez-Torres, Nuria Romero-Laorden, et al.. (2019). Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients. European Journal of Cancer. 109. 21–27. 192 indexed citations

10.

Pacheco-Barcía, Vilma, Rebeca Mondéjar, Olga Martínez‐Sáez, et al.. (2019). Safety and Oncological Outcomes of Bevacizumab Therapy in Patients With Advanced Colorectal Cancer and Self-expandable Metal Stents. Clinical Colorectal Cancer. 18(3). e287–e293. 14 indexed citations

11.

Rogado, Jacobo, Nuria Romero-Laorden, J.M. Sanchez Torres, et al.. (2019). Association of efficacy of anti-PD-1 immunotherapy in patients with advanced cancer with immune-related adverse events (irAEs).. Journal of Clinical Oncology. 37(15_suppl). e14064–e14064. 1 indexed citations

12.

Rogado, Jacobo, R. Mondéjar, Nuria Romero-Laorden, et al.. (2018). 190P Are neutrophil-to-lymphocyte ratio (NLR) and neutrophil count percentage (NCP) predictors of nivolumab outcome and toxicity in NSCLC?. Journal of Thoracic Oncology. 13(4). S114–S114. 1 indexed citations

13.

Rogado, Jacobo, R. Mondéjar, O. Donnay, et al.. (2018). 187P Nivolumab-related immune-related adverse events in advanced NSCLC predict therapeutic objective response. Journal of Thoracic Oncology. 13(4). S112–S112. 2 indexed citations

14.

Pacheco-Barcía, Vilma, T. France, George Zogopoulos, et al.. (2018). Gemcitabine plus nab-paclitaxel versus modified FOLFIRINOX as first line chemotherapy in metastatic pancreatic cancer: A comparison of toxicity and survival. Annals of Oncology. 29. v46–v46. 7 indexed citations

15.

Jiménez‐Fonseca, Paula, Caterina Calderón, Raquel Hernández, et al.. (2018). Factors associated with anxiety and depression in cancer patients prior to initiating adjuvant therapy. Clinical & Translational Oncology. 20(11). 1408–1415. 47 indexed citations

16.

Calderón, Caterina, Pere J. Ferrando, Urbano Lorenzo‐Seva, et al.. (2017). Psychometric properties of Liverpool Stoicism Scale (LSS) in a cohort of patients with resected cancer in adjuvant treatment. Anales de Psicología. 33(3). 621–621. 4 indexed citations

17.

Calderón, Caterina, Alberto Carmona‐Bayonas, Teresa García, et al.. (2016). Psychometric properties of the functional assessment for chronic illness therapy-spiritual wellbeing (FACIT-Sp) and its relationship wtih quality of Life on patients with non-metastatic resected cancer. Annals of Oncology. 27. vi471–vi471. 1 indexed citations

18.

Pericay, Carles, Nieves Martínez Lago, Ismael Macías, et al.. (2016). P-051 Preliminary clinical and pathologic characteristics of patients treated in second-line (2L) with 25 cycles (Cy) or more of FOLFIRI + Aflibercept (FA). Annals of Oncology. 27. ii15–ii15. 1 indexed citations

19.

Llovet, Patricia, Javier Sastre, Julián Sanz‐Ortega, et al.. (2015). Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy. Molecular Diagnosis & Therapy. 19(6). 397–408. 22 indexed citations

20.

Stephenson, Patricia, et al.. (1998). Improving women's health services in the Russian Federation. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact